LONDON, 22 July 2021 - DeepMind today announced its partnership with the European Molecular Biology Laboratory (EMBL), Europe's flagship laboratory for the life sciences, to make the most complete and ...

Researchers will have free access to chemogenomic databases developed by Galapagos under a €1.8 million licensing agreement between the Belgian drug discovery company and the European Molecular ...

The tremors that shook the life sciences community last December were mere prelude. Back then, at a biennial protein-prediction competition, an artificial intelligence (AI) tool called AlphaFold ...

On July 22, a historic milestone in artificial intelligence (AI) and biotechnology was achieved. U.K.-based DeepMind, a wholly owned subsidiary of Google-parent Alphabet Inc., and the European ...

AlphaFold program’s prediction of nearly 20,000 human protein structures now free for researchers Last year the artificial intelligence group DeepMind cracked a mystery that has flummoxed scientists ...

EMBL scientists apply and develop AI tools in collaborative life science research in many different areas, from structural biology and image analysis to omics and technology development. The German AI ...

We are pleased to announce that a tender process is now open and you are invited to submit a proposal for the requirements outlined in the ITT. The European Molecular Biology Laboratory (EMBL), is ...

DeepMind is partnering with EMBL to make the most complete and accurate database yet of the predicted human protein structures freely and openly available to the scientific community. The AlphaFold ...